Insider Transactions Reported by 9 Insiders of ADAPTIN BIO, INC.

Symbol
APTN on OTC
Location
Charlotte, NC

Key facts

  • APTN - ADAPTIN BIO, INC. has 9 insiders with reported activity on this page.
  • No net insider buy/sell flow is currently reported for the last year.
  • Recent transaction rows are available for direct filing-level review.

Change

  • No meaningful buy/sell imbalance is currently visible in the one-year window.
  • Activity will update as new Forms 3/4/5 are filed.

Research use

  • This page gives a plain-language issuer insider context before you inspect transaction-level evidence.
  • Use the filing links below to verify timestamps, codes, and ownership impacts directly from SEC forms.

Evidence

Filed on Form 4

Issuer insider activity is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Insider trading overview

Last 12 months

Insider buy and sell flow is broadly balanced over the last 12 months. No Buy or Sell transactions have been reported since 26 May 2025.

Buys

$0

Shares: 0

Insiders: 0

Sells

$0

Shares: 0

Insiders: 0

Net

$0

Shares: 0

Insiders: 0

Window (months) Buy shares Sell shares Buy $ Sell $ Net $
0-3 0 0 $0 $0 $0
3-6 0 0 $0 $0 $0
6-9 0 0 $0 $0 $0
9-12 0 0 $0 $0 $0

ADAPTIN BIO, INC. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Valuation Report Date
Michael J. Roberts President and CEO, Director, 10%+ Owner Mixed 08 Sep 2025
Simon Pedder Executive Chairman, Director, 10%+ Owner Mixed 08 Sep 2025
L. Arthur Hewitt Chief Development Officer Mixed 08 Sep 2025
J. Nick Riehle Director Mixed 08 Sep 2025
Anthony P. Zook Director Mixed 08 Sep 2025
Patrick Joseph Gallagher Director Mixed 08 Sep 2025
Timothy Maness Chief Financial Officer Mixed 08 Sep 2025
Lucius Partners LLC 10%+ Owner Mixed 11 Feb 2025
Nathan P. Pereira President, CEO, CFO, Director Mixed 09 Oct 2023

Top shareholders of ADAPTIN BIO, INC. (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
Michael J. Roberts
3/4/5 13D/G
President and CEO, Director, 10%+ Owner
27%
from 13D/G
2,598,854
mixed-class rows
08 Sep 2025
Simon Pedder
3/4/5 13D/G
Executive Chairman, Director, 10%+ Owner
12%
from 13D/G
1,120,802
mixed-class rows
08 Sep 2025
Lucius Partners LLC
3/4/5
10%+ Owner
class O/S missing
3,250,000
11 Feb 2025
Timothy Maness
3/4/5
Chief Financial Officer
class O/S missing
192,231
08 Sep 2025
Anthony P. Zook
3/4/5
Director
class O/S missing
109,847
08 Sep 2025
J. Nick Riehle
3/4/5
Director
class O/S missing
109,847
08 Sep 2025
L. Arthur Hewitt
3/4/5
Chief Development Officer
class O/S missing
109,847
08 Sep 2025
Patrick Joseph Gallagher
3/4/5
Director
class O/S missing
109,847
08 Sep 2025

Recent Insider Transactions by Companies or Individuals for ADAPTIN BIO, INC.

Showing up to 300 most recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
Anthony P. Zook Stock Option (right to buy) Award 109,847 109,847 08 Sep 2025 Direct
J. Nick Riehle Stock Option (right to buy) Award 109,847 109,847 08 Sep 2025 Direct
Patrick Joseph Gallagher Stock Option (right to buy) Award 109,847 109,847 08 Sep 2025 Direct
Michael J. Roberts Stock Option (right to buy) Award 439,386 439,386 08 Sep 2025 Direct
Simon Pedder Stock Option (right to buy) Award 192,231 192,231 08 Sep 2025 Direct
Timothy Maness Stock Option (right to buy) Award 192,231 192,231 08 Sep 2025 Direct
L. Arthur Hewitt Stock Option (right to buy) Award 109,847 109,847 08 Sep 2025 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .